Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular basis for sequence-specific DNA alkylation by CC-1065.

L H Hurley1, C S Lee, J P McGovren

  • 1Division of Medicinal Chemistry, College of Pharmacy, University of Texas, Austin 78712.

Biochemistry
|May 17, 1988
PubMed
Summary

CC-1065, an antitumor antibiotic, covalently binds to DNA at specific adenine sites. Its biological potency is directly linked to its DNA alkylation ability, with modifications affecting sequence specificity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heme oxygenase-mediated resistance to oxygen toxicity in hamster fibroblasts.

The Journal of biological chemistry·1997
Same author

Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen.

Journal of virology·1997
Same author

Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·1997
Same author

Development of jaundice in Korean neonates after cesarean section.

Acta paediatrica Japonica : Overseas edition·1997
Same author

On-line micellar electrokinetic chromatography-electrospray ionization mass spectrometry using anodically migrating micelles.

Analytical chemistry·1997
Same author

Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.

Neurology·1997

Area of Science:

  • Molecular Biology
  • Medicinal Chemistry
  • Anticancer Drug Development

Background:

  • CC-1065 is a potent antitumor antibiotic targeting DNA.
  • It functions by covalently binding to the N3 of adenine within DNA's minor groove.
  • The molecule comprises three pyrroloindole subunits, with the left-hand subunit possessing a reactive cyclopropyl group.

Purpose of the Study:

  • To evaluate the DNA alkylation, sequence specificity, and biological potency of CC-1065 and its synthetic analogues.
  • To investigate the relationship between drug structure and its DNA-binding and cytotoxic effects.
  • To compare the covalent adduct formation of analogues with varying numbers of nonreactive indole subunits.

Main Methods:

  • Assessing DNA alkylation and sequence specificity of CC-1065 and synthetic analogues.

Related Experiment Videos

  • Utilizing footprinting methods to detect noncovalent interactions.
  • Comparing covalent adduct formation in DNA fragments with different analogue structures.

    • Main Results:

    • Noncovalent interactions were too unstable for detection by footprinting.
    • Substituents on nonreactive segments modulate sequence specificity and alkylation intensity.
    • Biological potency strongly correlates with the ability to alkylate DNA.
    • Analogue structure influences the extent and sequence specificity of covalent adduct formation.

    Conclusions:

    • CC-1065's antitumor activity is dependent on its DNA alkylation capability.
    • Synthetic analogues can be designed to optimize sequence specificity and potency.
    • Understanding structure-activity relationships is key for developing novel DNA-targeting anticancer agents.